PHOREMOST
PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new โdruggableโ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel โtargetedโ therapies more efficiently to market and pass these cost savings onto patients.
PHOREMOST
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.phoremost.com
Total Employee:
1+
Status:
Active
Contact:
+4401223437110
Email Addresses:
[email protected]
Total Funding:
64.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Euro Microsoft Exchange Online
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Series B - PhoreMost
Trend Investment Group
Trend Investment Group investment in Series B - PhoreMost
Parkwalk Advisors
Parkwalk Advisors investment in Series B - PhoreMost
Jonathan Milner
Jonathan Milner investment in Series B - PhoreMost
Morningside Venture Investments
Morningside Venture Investments investment in Series B - PhoreMost
Business Growth Fund
Business Growth Fund investment in Series B - PhoreMost
Astellas Venture Management
Astellas Venture Management investment in Series B - PhoreMost
XtalPi
XtalPi investment in Series B - PhoreMost
Amadeus Capital Partners
Amadeus Capital Partners investment in Series A - PhoreMost
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - PhoreMost
Official Site Inspections
http://www.phoremost.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.28 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London